A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial

Autor: Krzysztof Milewski, Michel Noutsias, Maciej Kośmider, Robbert J. de Winter, Yoshinobu Onuma, Yuki Katagiri, Sjoerd H. Hofma, Patrick W. Serruys, Paweł Buszman, Bas J B Hamer, E. Karin Arkenbout, William Wijns, Philipp Lurz, Jochen Wöhrle, Aleksander Żurakowski, Pascal Goube, Taku Asano, Dieter Fischer, Markus Ferrari, Karel T. Koch, Roland P.T. Troquay, Rafał Wyderka, Guillaume Cayla, Ton Oude Ophuis, Sébastien Levesque, Gillian A.J. Jessurun

Publikováno v: Lancet, 391(10119), 431-440. Elsevier Limited
Lancet
Lancet, Elsevier, 2018, 391 (10119), pp.431--440. ⟨10.1016/S0140-6736(17)33103-3⟩
Lancet (UK), 391(10119), 431-440. Elsevier Ltd.

International audience; BACKGROUND: MiStent is a drug-eluting stent with a fully absorbable polymer coating containing and embedding a microcrystalline form of sirolimus into the vessel wall. It was developed to overcome the limitation of current dur

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c879f63e123c36a41e1fd19a71160dac
https://doi.org/10.1016/s0140-6736(17)33103-3

Novel paclitaxel-eluting, biodegradable polymer coated stent in the treatment of de novo coronary lesions: A prospective multicenter registry

Autor: Tadeusz Przewłocki, Leszek Kinasz, Maciej Kośmider, Marek Kondys, Jacek Janczak, Grzegorz L. Kaluza, Paweł Buszman, Jarosław Wójcik, Janusz Rzeźniczak, Stanislaw Trznadel, Robert J. Gil, Aleksander Zurakowski, Jaklik A, Stephan Kiesz, Marek Król, Łukasz Rzeszutko, Krzysztof Milewski

Publikováno v: Catheterization and Cardiovascular Interventions. 71:51-57

Objectives: The purpose of the present study was to evaluate the efficacy and safety of a biodegradable polymer coated, paclitaxel eluting stent (Luc-Chopin2) based on 9-months angiographic and 12-months clinical follow-up results. Background: First-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c29fd71c2ade63b7aa5d077b2c9b9389
https://doi.org/10.1002/ccd.21392

Complement activates neutrophils during PTCA procedure in patients with unstable angina pectoris

Autor: Zbigniew Baj, Małgorzata Banasik, Jan Kowalski, Ewa Głowacka, Julita Ciećwierz, Jarosław Paśnik, Maciej Kośmider, Lucjan Pawlicki

Publikováno v: International Journal of Cardiology. 58:229-240

We estimated adherence, aggregation and chemiluminescence of neutrophils as well as concentrations of C3c, C4 and C5 complement components and complement haemolytic activity (CH50) in 27 patients with unstable angina pectoris subjected to percutaneou

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c969b2f6f766518683e06b40638723c1
https://doi.org/10.1016/s0167-5273(96)02870-7

Impact of diabetes on survival in patients with ST-segment elevation myocardial infarction treated by primary angioplasty: insights from the POLISH STEMI registry

Autor: Giuseppe, De Luca, Lukasz A, Małek, Paweł, Maciejewski, Wojciech, Wasek, Maciej, Niewada, Bogumił, Kamiński, Janusz, Drze wiecki, Maciej, Kośmider, Jacek, Kubica, Witold, Ruzyłło, Jan Z, Peruga, Dariusz, Dudek, Grzegorz, Opolski, Sławomir, Dobrzycki, Robert J, Gil, Adam, Witkowski, Bogdan, Januś

Publikováno v: Atherosclerosis. 210(2)

It has been shown that, among patients with ST-segment elevation myocardial infarction (STEMI), diabetes is associated with a significantly higher mortality. The aim of this study was to investigate in a large cohort of patients the impact of diabete

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8fdd1669d7434ff631d1a105343b340
https://pubmed.ncbi.nlm.nih.gov/20083247

Acute myocardial infarction in the elderly. Is primary coronary angioplasty the treatment of choice? In-hospital follow-up results

Autor: Marzenna, Zielińska, Halina, Bolińska, Krzysztof, Kaczmarek, Jan, Krekora, Maciej, Kuczborski, Maciej, Kośmider, Włodzimierz, Koniarek

Publikováno v: Kardiologia polska. 60(2)

Acute myocardial infarction (AMI) is one of the main causes of death in the elderly, however, the optimal therapy of AMI in this age-group has not yet been established.To compare the early outcome of patients with AMI agedor =75 years who underwent p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ab4410fe978b9d03e52d4b997588bf42
https://pubmed.ncbi.nlm.nih.gov/15226801